Literature DB >> 25419767

Methicillin-resistant Staphylococcus aureus: site of acquisition and strain variation in high-risk nursing home residents with indwelling devices.

Kristen E Gibson1, Sara E McNamara, Marco Cassone, Mary Beth Perri, Marcus Zervos, Lona Mody.   

Abstract

OBJECTIVE: Characterize the clinical and molecular epidemiology of new methicillin-resistant Staphylococcus aureus (MRSA) acquisitions at nasal and extranasal sites among high-risk nursing home (NH) residents.
DESIGN: Multicenter prospective observational study.
SETTING: Six NHs in southeast Michigan. PARTICIPANTS: A total of 120 NH residents with an indwelling device (feeding tube and/or urinary catheter).
METHODS: Active surveillance cultures from the nares, oropharynx, groin, perianal area, wounds (if present), and device insertion site(s) were collected upon enrollment, at day 14, and monthly thereafter. Pulsed-field gel electrophoresis and polymerase chain reaction for SCCmec, agr, and Panton-Valentine leukocidin were performed.
RESULTS: Of 120 participants observed for 16,290 device-days, 50 acquired MRSA (78% transiently, 22% persistently). New MRSA acquisitions were common in extranasal sites, particularly at device insertion, groin, and perianal areas (27%, 23%, and 17.6% of all acquisitions, respectively). Screening extranasal sites greatly increases the detection of MRSA colonization (100% of persistent carriers and 97.4% of transient carriers detected with nares, groin, perianal, and device site sampling vs 54.5% and 25.6%, respectively, for nares samples alone). Colonization at suprapubic urinary catheter sites generally persisted. Healthcare-associated MRSA (USA100 and USA100 variants) were the dominant strains (79.3% of all new acquisition isolates). Strain diversity was more common in transient carriers, including acquisition of USA500 and USA300 strains.
CONCLUSION: Indwelling device insertion sites as well as the groin and perianal area are important sites of new MRSA acquisitions in NH residents and play a role in the persistency of MRSA carriage. Clonal types differ among persistent and transient colonizers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25419767      PMCID: PMC4394900          DOI: 10.1086/678599

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  30 in total

Review 1.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.

Authors:  J Kluytmans; A van Belkum; H Verbrugh
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups.

Authors:  B Strommenger; C Cuny; G Werner; W Witte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-02       Impact factor: 3.267

3.  Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus.

Authors:  Kunyan Zhang; Jo-Ann McClure; Sameer Elsayed; Thomas Louie; John M Conly
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Human factor in Staphylococcus aureus nasal carriage.

Authors:  Jan Nouwen; Hélène Boelens; Alex van Belkum; Henri Verbrugh
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state.

Authors:  M F VandenBergh; E P Yzerman; A van Belkum; H A Boelens; M Sijmons; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 6.  Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections.

Authors:  J A J W Kluytmans; H F L Wertheim
Journal:  Infection       Date:  2005-02       Impact factor: 3.553

7.  Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule".

Authors:  Jan L Nouwen; Alewijn Ott; Marjolein F Q Kluytmans-Vandenbergh; Hélène A M Boelens; Albert Hofman; Alex van Belkum; Henri A Verbrugh
Journal:  Clin Infect Dis       Date:  2004-08-26       Impact factor: 9.079

8.  Methicillin-resistant staphylococcal colonization and infection in a long-term care facility.

Authors:  R R Muder; C Brennen; M M Wagener; R M Vickers; J D Rihs; G A Hancock; Y C Yee; J M Miller; V L Yu
Journal:  Ann Intern Med       Date:  1991-01-15       Impact factor: 25.391

9.  Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility.

Authors:  S F Bradley; M S Terpenning; M A Ramsey; L T Zarins; K A Jorgensen; W S Sottile; D R Schaberg; C A Kauffman
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

10.  Diversity of methicillin-resistant Staphylococcus aureus strains isolated from residents of 26 nursing homes in Orange County, California.

Authors:  Lyndsey O Hudson; Courtney Reynolds; Brian G Spratt; Mark C Enright; Victor Quan; Diane Kim; Paul Hannah; Lydia Mikhail; Richard Alexander; Douglas F Moore; Daniel Godoy; Cynthia J Bishop; Susan S Huang
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

View more
  12 in total

1.  Colonization with Multi-Drug Resistant Organisms in Nursing Homes: Scope, Importance, and Management.

Authors:  Marco Cassone; Lona Mody
Journal:  Curr Geriatr Rep       Date:  2015-03

Review 2.  Evaluation and management of Staphylococcus aureus bacteriuria: an updated review.

Authors:  Stamatis Karakonstantis; Dimitra Kalemaki
Journal:  Infection       Date:  2017-11-11       Impact factor: 3.553

Review 3.  Template for an Antibiotic Stewardship Policy for Post-Acute and Long-Term Care Settings.

Authors:  Robin L P Jump; Swati Gaur; Morgan J Katz; Christopher J Crnich; Ghinwa Dumyati; Muhammad S Ashraf; Elizabeth Frentzel; Steven J Schweon; Philip Sloane; David Nace
Journal:  J Am Med Dir Assoc       Date:  2017-09-19       Impact factor: 4.669

4.  Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Colonization.

Authors:  Marco Cassone; Julia Mantey; Mary Beth Perri; Kristen Gibson; Bonnie Lansing; Sara McNamara; Payal K Patel; Vincent C C Cheng; Maroya S Walters; Nimalie D Stone; Marcus J Zervos; Lona Mody
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 5.  Infection Control in Alternative Health Care Settings: An Update.

Authors:  Elaine Flanagan; Marco Cassone; Ana Montoya; Lona Mody
Journal:  Infect Dis Clin North Am       Date:  2016-09       Impact factor: 5.982

6.  MRSA Transmission in Intensive Care Units: Genomic Analysis of Patients, Their Environments, and Healthcare Workers.

Authors:  Kyle J Popovich; Stefan J Green; Koh Okamoto; Yoona Rhee; Mary K Hayden; Michael Schoeny; Evan S Snitkin; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 20.999

7.  Estimation of the incidence of MRSA patients: evaluation of a surveillance system using health insurance claim data.

Authors:  S Tanihara; S Suzuki
Journal:  Epidemiol Infect       Date:  2016-08       Impact factor: 2.451

8.  Integrated MRSA-Management (IMM) with prolonged decolonization treatment after hospital discharge is effective: a single centre, non-randomised open-label trial.

Authors:  Bernhard Jahn; Trudy M Wassenaar; Annemarie Stroh
Journal:  Antimicrob Resist Infect Control       Date:  2016-06-14       Impact factor: 4.887

Review 9.  Challenges and Strategies for Prevention of Multidrug-Resistant Organism Transmission in Nursing Homes.

Authors:  Ghinwa Dumyati; Nimalie D Stone; David A Nace; Christopher J Crnich; Robin L P Jump
Journal:  Curr Infect Dis Rep       Date:  2017-04       Impact factor: 3.725

10.  MRSA Prevalence and Risk Factors among Health Personnel and Residents in Nursing Homes in Hamburg, Germany - A Cross-Sectional Study.

Authors:  Claudia Peters; Madeleine Dulon; Olaf Kleinmüller; Albert Nienhaus; Anja Schablon
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.